Last €30.13 EUR
Change Today -0.80 / -2.59%
Volume 0.0
As of 2:15 AM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

olympus corp (OLY1) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/23/15 - €32.10
52 Week Low
02/4/14 - €20.03
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for OLYMPUS CORP (OLY1)

Related News

No related news articles were found.

olympus corp (OLY1) Related Businessweek News

View More BusinessWeek News

olympus corp (OLY1) Details

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates in four segments: Medical Business, Scientific Solutions Business, Imaging Business, and Others Business. The Medical Business segment provides endoscopy systems comprising videoscopes, video processors, light sources, and liquid crystal display panels; peripheral equipment, such as image recording devices, endoscope cleaning systems, sterilization systems, etc.; surgical video endoscopy systems, peripheral devices for endoscopic surgery, electrosurgical knives, etc.; and endoscopic devices for various diagnostic and treatment procedures, including biopsy forceps, high-frequency polypectomy snares, grasping forceps, stone retrieval and lithotriptor baskets, hemostasis accessories, etc. The Scientific Solutions Business segment offers upright and polarizing microscopes, inverted microscopes, laser confocal microscopes, box-type fluorescence imaging devices, stereo microscopes, fluorescence macro microscopes, microscope digital cameras, imaging software, bio-imaging systems, and virtual slide systems; and metallurgical microscopes, semiconductor inspection microscopes, laser and measuring microscopes, microscopic 3D measurement systems, industrial videoscopes and fiberscopes, industrial rigid scopes, ultrasonic flaw detectors, eddy current flaw detectors, phased array flaw detectors, X-ray diffraction analyzers, and peripheral equipment. The Imaging Business segment offers digital single-lens cameras, compact digital cameras and related products, digital camera lens barrels, and optical components, as well as IC recorders and binoculars. The Others Business segment manufactures biomedical materials, as well as conducts system development and other business activities. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

30,702 Employees
Last Reported Date: 06/26/14
Founded in 1919

olympus corp (OLY1) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

olympus corp (OLY1) Key Developments

Olympus Corporation Provides Earnings Guidance for the Fiscal Year Ending March 31, 2015

Olympus Corporation provided earnings guidance for the fiscal year ending March 31, 2015. For the year, the company expected net sales of JPY 760,000 million, operating income of JPY 88,000 million, ordinary income of JPY 70,000 million, and net income of JPY 45,000 million.

Olympus Corporation, H1 2015 Earnings Call, Nov 07, 2014

Olympus Corporation, H1 2015 Earnings Call, Nov 07, 2014

Olympus Corporation Reports Consolidated Earnings Results for the First Half of 2015; Provides Earnings Guidance for the Full Year of 2015

Olympus Corporation reported consolidated earnings results for the first half of 2015. For the period, the company reported net sales increased 6% year-on-year to JPY 355 billion. And operating income rose 35% to JPY 38.4 billion. Higher operating income was supported by the ongoing strong performance of the Medical business as well as the benefits of the yen depreciation. Ordinary income was up 75% year-on-year to JPY 29.7 billion. This sharp increase can be attributed to continuing efforts to reduce interest-bearing debt and the subsequent improvement in the balance of non-operating income and expenses. Net income totaled JPY 22.3 billion, improving due to its substantial year-on-year decline in extraordinary loss. Cash flow from operating activities was relatively unchanged year-on-year at JPY 29.6 billion. For the full year of fiscal 2015, the forecast project that net sales will increase 7% year-on-year to JPY 760 billion, operating income will rise 20% to JPY 88 billion and net income will be 3.3x higher in fiscal 2014 at JPY 45 billion.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OLY1:GR €30.13 EUR -0.80

OLY1 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Avery Dennison Corp $52.76 USD 0.00
Boston Scientific Corp $14.85 USD +0.26
Hoya Corp ¥4,599 JPY +60.00
Nikon Corp ¥1,504 JPY -1.00
Smith & Nephew PLC 1,202 GBp +2.00
View Industry Companies

Industry Analysis


Industry Average

Valuation OLY1 Industry Range
Price/Earnings 30.1x
Price/Sales 1.8x
Price/Book 3.6x
Price/Cash Flow 16.7x
TEV/Sales 1.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OLYMPUS CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at